- Corporate Officers - S
- Scangos George A
Insider Trading History of Scangos George A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Scangos George A since 2005.
This trader's CIK number is 1202102.
At the time of last reporting, Scangos George A was the Director of Vir Biotechnology, Inc.. (stock ticker symbol VIR).
Also see all insider trading activities at Vir Biotechnology, Inc..
Note that in the past
SCANGOS GEORGE A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Exelixis, Inc. (EXEL) by Scangos George A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | EXEL | 0 | $0 | 425,000 | $9,844,590 | 51,686 | $268,767 |
| 2019 | EXEL | 0 | $0 | 355,000 | $7,581,833 | 15,000 | $68,550 |
| 2018 | EXEL | 0 | $0 | 130,000 | $2,378,400 | 123,333 | $687,315 |
| 2016 | EXEL | 0 | $0 | 204,894 | $3,649,177 | 358,332 | $3,221,404 |
| 2008 | EXEL | 25,000 | $80,000 | 25,000 | $181,064 | 0 | $0 |
| 2007 | EXEL | 0 | $0 | 92,500 | $958,594 | 0 | $0 |
| 2006 | EXEL | 0 | $0 | 130,000 | $1,280,887 | 0 | $0 |
| 2005 | EXEL | 0 | $0 | 47,500 | $377,434 | 0 | $0 |
Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Scangos George A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ANDS | 10,000 | $27,000 | 0 | $0 | 0 | $0 |
| 2007 | ANDS | 22,188 | $48,480 | 0 | $0 | 0 | $0 |
| 2004 | ANDS | 1,000 | $7,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biogen Inc. (BIIB) by Scangos George A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | BIIB | 0 | $0 | 6,629 | $1,877,618 | 11,274 | $0 |
| 2015 | BIIB | 0 | $0 | 5,448 | $2,216,446 | 45,702 | $0 |
| 2014 | BIIB | 0 | $0 | 53,565 | $17,373,589 | 60,631 | $0 |
| 2013 | BIIB | 0 | $0 | 19,185 | $4,119,120 | 49,939 | $0 |
| 2012 | BIIB | 0 | $0 | 18,273 | $2,640,105 | 40,172 | $0 |
| 2011 | BIIB | 0 | $0 | 12,347 | $1,313,992 | 21,341 | $0 |
Yearly summary of insider trading at Vir Biotechnology, Inc. (VIR) by Scangos George A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VIR | 0 | $0 | 21,020 | $202,637 | 0 | $0 |
| 2024 | VIR | 0 | $0 | 55,500 | $591,026 | 0 | $0 |
| 2023 | VIR | 0 | $0 | 55,500 | $1,435,475 | 0 | $0 |
| 2022 | VIR | 0 | $0 | 27,750 | $863,377 | 0 | $0 |
Insider trading activities at 4 companies by Scangos George A:
1. Exelixis, Inc. (EXEL)
2. Anadys Pharmaceuticals Inc (ANDS)
3. Biogen Inc. (BIIB)
4. Vir Biotechnology, Inc. (VIR)
Table 1. Insider trading of Exelixis, Inc. (EXEL) by Scangos George A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-05-18 | EXEL | Sale | 75,000 | 25.96 | 1,947,000 |
| 2020-05-15 | EXEL | Option Ex | 51,686 | 5.20 | 268,767 |
| 2020-04-24 | EXEL | Sale | 15,000 | 26.24 | 393,600 |
| 2020-04-23 | EXEL | Sale | 100,000 | 25.95 | 2,595,500 |
| 2020-04-22 | EXEL | Sale | 4,200 | 25.05 | 105,210 |
| 2020-04-21 | EXEL | Sale | 5,800 | 25.04 | 145,232 |
| 2020-04-20 | EXEL | Sale | 50,000 | 24.05 | 1,202,650 |
| 2020-04-15 | EXEL | Sale | 25,000 | 18.31 | 457,749 |
| 2020-04-07 | EXEL | Sale | 16,435 | 18.25 | 299,938 |
| 2020-04-08 | EXEL | Sale | 7,065 | 18.35 | 129,642 |
| 2020-03-31 | EXEL | Sale | 1,500 | 18.06 | 27,089 |
| 2020-02-18 | EXEL | Sale | 50,000 | 20.73 | 1,036,500 |
| 2020-02-11 | EXEL | Sale | 4,000 | 20.14 | 80,560 |
| 2020-02-12 | EXEL | Sale | 21,000 | 20.02 | 420,420 |
| 2020-01-22 | EXEL | Sale | 25,000 | 19.75 | 493,750 |
| 2020-01-15 | EXEL | Sale | 25,000 | 20.39 | 509,750 |
| 2019-12-27 | EXEL | Sale | 25,000 | 18.25 | 456,250 |
| 2019-08-01 | EXEL | Sale | 40,000 | 20.86 | 834,200 |
| 2019-07-01 | EXEL | Sale | 40,000 | 21.58 | 863,199 |
| 2019-06-03 | EXEL | Sale | 25,000 | 19.61 | 490,250 |
| 2019-06-04 | EXEL | Sale | 15,000 | 20.00 | 300,000 |
| 2019-05-21 | EXEL | Option Ex | 15,000 | 4.57 | 68,550 |
| 2019-05-01 | EXEL | Sale | 25,000 | 19.75 | 493,750 |
| 2019-05-02 | EXEL | Sale | 15,000 | 20.00 | 300,000 |
| 2019-04-03 | EXEL | Sale | 5,000 | 25.03 | 125,150 |
| 2019-04-01 | EXEL | Sale | 40,000 | 24.02 | 960,800 |
| 2019-03-14 | EXEL | Sale | 5,000 | 25.00 | 125,000 |
| 2019-03-01 | EXEL | Sale | 40,000 | 22.66 | 906,400 |
| 2019-02-01 | EXEL | Sale | 40,000 | 23.53 | 941,200 |
| 2019-01-03 | EXEL | Sale | 96 | 20.00 | 1,920 |
| 2019-01-02 | EXEL | Sale | 39,904 | 19.64 | 783,714 |
| 2018-11-29 | EXEL | Sale | 6,500 | 20.00 | 130,000 |
| 2018-11-30 | EXEL | Sale | 8,500 | 20.00 | 170,000 |
| 2018-12-03 | EXEL | Sale | 40,000 | 21.16 | 846,400 |
| 2018-11-01 | EXEL | Sale | 25,000 | 14.57 | 364,250 |
| 2018-10-01 | EXEL | Sale | 25,000 | 17.86 | 446,500 |
| 2018-09-24 | EXEL | Sale | 25,000 | 16.85 | 421,250 |
| 2018-08-10 | EXEL | Option Ex | 108,333 | 4.73 | 512,415 |
| 2018-05-15 | EXEL | Option Ex | 15,000 | 11.66 | 174,900 |
| 2016-12-07 | EXEL | Sale | 176 | 17.90 | 3,150 |
| 2016-12-07 | EXEL | Option Ex | 356 | 8.99 | 3,200 |
| 2016-12-05 | EXEL | Sale | 204,718 | 17.81 | 3,646,027 |
| 2016-12-05 | EXEL | Option Ex | 357,976 | 8.99 | 3,218,204 |
| 2008-10-30 | EXEL | Buy | 25,000 | 3.20 | 80,000 |
| 2008-02-27 | EXEL | Sale | 2,500 | 6.54 | 16,357 |
| 2008-02-22 | EXEL | Sale | 2,500 | 5.86 | 14,640 |
| 2008-02-13 | EXEL | Sale | 2,500 | 7.05 | 17,632 |
| 2008-02-06 | EXEL | Sale | 2,500 | 6.87 | 17,172 |
| 2008-01-28 | EXEL | Sale | 2,500 | 7.13 | 17,830 |
| 2008-01-28 | EXEL | Sale | 2,500 | 7.13 | 17,830 |
| 2008-01-23 | EXEL | Sale | 2,500 | 7.10 | 17,752 |
| 2008-01-18 | EXEL | Sale | 2,500 | 7.66 | 19,147 |
| 2008-01-07 | EXEL | Sale | 2,500 | 8.41 | 21,035 |
| 2007-12-31 | EXEL | Sale | 2,500 | 8.67 | 21,669 |
| 2007-12-24 | EXEL | Sale | 2,500 | 9.24 | 23,090 |
| 2007-12-19 | EXEL | Sale | 2,500 | 9.09 | 22,717 |
| 2007-12-10 | EXEL | Sale | 2,500 | 8.64 | 21,589 |
| 2007-12-05 | EXEL | Sale | 2,500 | 8.80 | 21,995 |
| 2007-11-29 | EXEL | Sale | 2,500 | 8.85 | 22,115 |
| 2007-11-21 | EXEL | Sale | 2,500 | 8.13 | 20,337 |
| 2007-11-12 | EXEL | Sale | 2,500 | 9.18 | 22,940 |
| 2007-11-09 | EXEL | Sale | 2,500 | 11.31 | 28,267 |
| 2007-07-26 | EXEL | Sale | 2,500 | 10.20 | 25,502 |
| 2007-07-20 | EXEL | Sale | 2,500 | 11.38 | 28,462 |
| 2007-07-12 | EXEL | Sale | 2,500 | 11.64 | 29,107 |
| 2007-07-06 | EXEL | Sale | 2,500 | 11.85 | 29,632 |
| 2007-06-29 | EXEL | Sale | 2,500 | 12.21 | 30,527 |
| 2007-06-20 | EXEL | Sale | 2,500 | 11.67 | 29,177 |
| 2007-06-11 | EXEL | Sale | 2,500 | 10.95 | 27,362 |
| 2007-06-08 | EXEL | Sale | 2,500 | 10.76 | 26,892 |
| 2007-05-30 | EXEL | Sale | 2,500 | 11.32 | 28,307 |
| 2007-05-24 | EXEL | Sale | 2,500 | 11.31 | 28,267 |
| 2007-05-14 | EXEL | Sale | 2,500 | 11.33 | 28,322 |
| 2007-05-09 | EXEL | Sale | 2,500 | 11.52 | 28,802 |
| 2007-05-02 | EXEL | Sale | 2,500 | 10.75 | 26,875 |
| 2007-04-24 | EXEL | Sale | 2,500 | 11.03 | 27,567 |
| 2007-04-20 | EXEL | Sale | 2,500 | 10.94 | 27,337 |
| 2007-04-10 | EXEL | Sale | 2,500 | 10.97 | 27,427 |
| 2007-04-03 | EXEL | Sale | 2,500 | 10.16 | 25,407 |
| 2007-03-22 | EXEL | Sale | 2,500 | 10.18 | 25,445 |
| 2007-03-16 | EXEL | Sale | 2,500 | 9.57 | 23,920 |
| 2007-03-05 | EXEL | Sale | 2,500 | 9.22 | 23,062 |
| 2007-02-27 | EXEL | Sale | 2,500 | 10.09 | 25,222 |
| 2007-02-21 | EXEL | Sale | 2,500 | 11.32 | 28,300 |
| 2007-02-12 | EXEL | Sale | 2,500 | 10.99 | 27,467 |
| 2007-02-08 | EXEL | Sale | 2,500 | 10.42 | 26,052 |
| 2007-02-01 | EXEL | Sale | 2,500 | 9.99 | 24,970 |
| 2007-01-26 | EXEL | Sale | 2,500 | 9.55 | 23,867 |
| 2007-01-17 | EXEL | Sale | 2,500 | 10.10 | 25,250 |
| 2007-01-08 | EXEL | Sale | 2,500 | 9.44 | 23,602 |
| 2007-01-03 | EXEL | Sale | 2,500 | 9.37 | 23,415 |
| 2006-12-27 | EXEL | Sale | 2,500 | 9.25 | 23,115 |
| 2006-12-18 | EXEL | Sale | 2,500 | 9.18 | 22,950 |
| 2006-12-12 | EXEL | Sale | 2,500 | 9.03 | 22,575 |
| 2006-12-06 | EXEL | Sale | 2,500 | 8.95 | 22,362 |
| 2006-11-28 | EXEL | Sale | 2,500 | 8.49 | 21,227 |
| 2006-11-21 | EXEL | Sale | 2,500 | 9.04 | 22,605 |
| 2006-11-13 | EXEL | Sale | 2,500 | 8.72 | 21,812 |
| 2006-11-09 | EXEL | Sale | 2,500 | 8.74 | 21,857 |
| 2006-11-03 | EXEL | Sale | 2,500 | 8.30 | 20,745 |
| 2006-10-24 | EXEL | Sale | 2,500 | 10.00 | 25,002 |
| 2006-10-16 | EXEL | Sale | 2,500 | 10.00 | 25,010 |
| 2006-10-13 | EXEL | Sale | 2,500 | 9.66 | 24,145 |
| 2006-10-05 | EXEL | Sale | 2,500 | 8.90 | 22,247 |
| 2006-09-26 | EXEL | Sale | 2,500 | 8.98 | 22,462 |
| 2006-09-20 | EXEL | Sale | 2,500 | 9.30 | 23,262 |
| 2006-09-14 | EXEL | Sale | 2,500 | 9.21 | 23,032 |
| 2006-09-07 | EXEL | Sale | 2,500 | 9.02 | 22,540 |
| 2006-08-31 | EXEL | Sale | 2,500 | 9.76 | 24,394 |
| 2006-08-24 | EXEL | Sale | 2,500 | 8.11 | 20,280 |
| 2006-08-14 | EXEL | Sale | 2,500 | 7.80 | 19,512 |
| 2006-08-09 | EXEL | Sale | 2,500 | 8.27 | 20,684 |
| 2006-08-03 | EXEL | Sale | 2,500 | 8.93 | 22,317 |
| 2006-07-28 | EXEL | Sale | 2,500 | 9.00 | 22,490 |
| 2006-07-20 | EXEL | Sale | 2,500 | 9.10 | 22,752 |
| 2006-07-20 | EXEL | Sale | 2,500 | 9.10 | 22,752 |
| 2006-07-11 | EXEL | Sale | 2,500 | 9.73 | 24,315 |
| 2006-07-05 | EXEL | Sale | 2,500 | 9.86 | 24,640 |
| 2006-06-29 | EXEL | Sale | 2,500 | 9.88 | 24,695 |
| 2006-06-21 | EXEL | Sale | 2,500 | 9.81 | 24,517 |
| 2006-06-08 | EXEL | Sale | 2,500 | 10.52 | 26,297 |
| 2006-05-30 | EXEL | Sale | 2,500 | 10.27 | 25,680 |
| 2006-05-22 | EXEL | Sale | 2,500 | 9.34 | 23,360 |
| 2006-05-10 | EXEL | Sale | 2,500 | 10.99 | 27,470 |
| 2006-04-27 | EXEL | Sale | 2,500 | 10.83 | 27,070 |
| 2006-04-17 | EXEL | Sale | 2,500 | 10.73 | 26,825 |
| 2006-04-11 | EXEL | Sale | 2,500 | 10.85 | 27,112 |
| 2006-04-06 | EXEL | Sale | 2,500 | 11.47 | 28,677 |
| 2006-03-27 | EXEL | Sale | 2,500 | 11.17 | 27,925 |
| 2006-03-21 | EXEL | Sale | 2,500 | 11.52 | 28,809 |
| 2006-03-15 | EXEL | Sale | 2,500 | 11.48 | 28,705 |
| 2006-03-09 | EXEL | Sale | 2,500 | 11.35 | 28,375 |
| 2006-03-09 | EXEL | Sale | 2,500 | 11.35 | 28,375 |
| 2006-03-09 | EXEL | Sale | 2,500 | 11.35 | 28,375 |
| 2006-03-02 | EXEL | Sale | 2,500 | 11.21 | 28,025 |
| 2006-02-24 | EXEL | Sale | 2,500 | 10.45 | 26,127 |
| 2006-02-15 | EXEL | Sale | 2,500 | 10.11 | 25,262 |
| 2006-02-15 | EXEL | Sale | 2,500 | 10.11 | 25,262 |
| 2006-02-09 | EXEL | Sale | 2,500 | 10.38 | 25,962 |
| 2006-01-30 | EXEL | Sale | 2,500 | 10.89 | 27,227 |
| 2006-01-19 | EXEL | Sale | 2,500 | 11.15 | 27,877 |
| 2006-01-10 | EXEL | Sale | 2,500 | 10.80 | 27,007 |
| 2006-01-05 | EXEL | Sale | 2,500 | 9.91 | 24,787 |
| 2005-12-28 | EXEL | Sale | 2,500 | 9.71 | 24,280 |
| 2005-12-19 | EXEL | Sale | 2,500 | 8.85 | 22,120 |
| 2005-12-15 | EXEL | Sale | 2,500 | 9.01 | 22,527 |
| 2005-12-06 | EXEL | Sale | 2,500 | 8.49 | 21,227 |
| 2005-11-28 | EXEL | Sale | 2,500 | 8.09 | 20,230 |
| 2005-11-22 | EXEL | Sale | 2,500 | 8.57 | 21,415 |
| 2005-11-18 | EXEL | Sale | 2,500 | 8.50 | 21,255 |
| 2005-11-08 | EXEL | Sale | 2,500 | 8.79 | 21,987 |
| 2005-11-03 | EXEL | Sale | 2,500 | 7.98 | 19,955 |
| 2005-10-26 | EXEL | Sale | 2,500 | 7.79 | 19,465 |
| 2005-10-20 | EXEL | Sale | 2,500 | 7.33 | 18,332 |
| 2005-10-10 | EXEL | Sale | 2,500 | 7.25 | 18,127 |
| 2005-10-05 | EXEL | Sale | 2,500 | 7.59 | 18,965 |
| 2005-09-27 | EXEL | Sale | 2,500 | 7.39 | 18,465 |
| 2005-04-21 | EXEL | Sale | 2,500 | 8.40 | 21,012 |
| 2005-04-19 | EXEL | Sale | 2,500 | 7.11 | 17,765 |
| 2005-04-05 | EXEL | Sale | 2,500 | 6.70 | 16,750 |
| 2005-03-21 | EXEL | Sale | 2,500 | 6.75 | 16,885 |
| 2005-03-15 | EXEL | Sale | 2,500 | 6.67 | 16,672 |
Table 2. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Scangos George A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-08-26 | ANDS | Buy | 10,000 | 2.70 | 27,000 |
| 2007-08-31 | ANDS | Buy | 22,188 | 2.19 | 48,480 |
| 2004-03-31 | ANDS | Buy | 1,000 | 7.00 | 7,000 |
Table 3. Insider trading of Biogen Inc. (BIIB) by Scangos George A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-07-21 | BIIB | Sale | 157 | 280.00 | 43,960 |
| 2016-06-03 | BIIB | Sale | 842 | 290.00 | 244,180 |
| 2016-06-01 | BIIB | Sale | 487 | 287.97 | 140,241 |
| 2016-05-31 | BIIB | Sale | 3,368 | 290.00 | 976,720 |
| 2016-05-25 | BIIB | Sale | 157 | 280.00 | 43,960 |
| 2016-05-02 | BIIB | Sale | 487 | 274.74 | 133,798 |
| 2016-04-06 | BIIB | Sale | 157 | 280.00 | 43,960 |
| 2016-04-01 | BIIB | Sale | 487 | 258.83 | 126,050 |
| 2016-02-17 | BIIB | Sale | 487 | 256.16 | 124,749 |
| 2016-02-09 | BIIB | Option Ex | 11,274 | .00 | 0 |
| 2015-06-01 | BIIB | Sale | 1,362 | 398.87 | 543,260 |
| 2015-04-01 | BIIB | Sale | 1,362 | 423.20 | 576,398 |
| 2015-03-13 | BIIB | Sale | 537 | 412.69 | 221,613 |
| 2015-03-02 | BIIB | Sale | 825 | 410.67 | 338,802 |
| 2015-02-19 | BIIB | Sale | 537 | 401.04 | 215,358 |
| 2015-02-17 | BIIB | Sale | 825 | 389.11 | 321,015 |
| 2015-02-12 | BIIB | Option Ex | 15,599 | .00 | 0 |
| 2015-02-09 | BIIB | Option Ex | 11,270 | .00 | 0 |
| 2015-02-10 | BIIB | Option Ex | 18,833 | .00 | 0 |
| 2014-11-03 | BIIB | Sale | 1,128 | 320.78 | 361,839 |
| 2014-10-01 | BIIB | Sale | 1,127 | 330.97 | 373,003 |
| 2014-09-02 | BIIB | Sale | 1,128 | 345.47 | 389,690 |
| 2014-08-01 | BIIB | Sale | 1,128 | 332.93 | 375,545 |
| 2014-07-16 | BIIB | Sale | 12,316 | 312.37 | 3,847,148 |
| 2014-07-15 | BIIB | Option Ex | 21,339 | .00 | 0 |
| 2014-06-02 | BIIB | Sale | 484 | 318.93 | 154,362 |
| 2014-05-01 | BIIB | Sale | 2,123 | 285.60 | 606,322 |
| 2014-04-01 | BIIB | Sale | 2,123 | 308.42 | 654,775 |
| 2014-03-10 | BIIB | Sale | 26,124 | 332.92 | 8,697,097 |
| 2014-03-03 | BIIB | Sale | 2,942 | 335.79 | 987,894 |
| 2014-02-13 | BIIB | Sale | 486 | 316.81 | 153,969 |
| 2014-02-12 | BIIB | Option Ex | 9,189 | .00 | 0 |
| 2014-02-11 | BIIB | Sale | 2,456 | 314.31 | 771,945 |
| 2014-02-09 | BIIB | Option Ex | 11,270 | .00 | 0 |
| 2014-02-10 | BIIB | Option Ex | 18,833 | .00 | 0 |
| 2013-11-01 | BIIB | Sale | 2,239 | 245.57 | 549,831 |
| 2013-10-01 | BIIB | Sale | 2,239 | 242.85 | 543,741 |
| 2013-09-03 | BIIB | Sale | 2,239 | 214.88 | 481,116 |
| 2013-08-01 | BIIB | Sale | 2,239 | 218.82 | 489,937 |
| 2013-07-16 | BIIB | Sale | 2,239 | 223.94 | 501,401 |
| 2013-07-15 | BIIB | Option Ex | 21,339 | .00 | 0 |
| 2013-06-03 | BIIB | Sale | 1,598 | 234.16 | 374,187 |
| 2013-05-01 | BIIB | Sale | 1,598 | 215.39 | 344,193 |
| 2013-04-01 | BIIB | Sale | 1,598 | 193.66 | 309,468 |
| 2013-03-01 | BIIB | Sale | 1,598 | 165.30 | 264,149 |
| 2013-02-13 | BIIB | Sale | 1,598 | 163.39 | 261,097 |
| 2013-02-09 | BIIB | Option Ex | 9,767 | .00 | 0 |
| 2013-02-10 | BIIB | Option Ex | 18,833 | .00 | 0 |
| 2012-11-01 | BIIB | Sale | 2,472 | 139.28 | 344,292 |
| 2012-10-01 | BIIB | Sale | 3,654 | 149.16 | 545,030 |
| 2012-09-04 | BIIB | Sale | 3,654 | 145.90 | 533,118 |
| 2012-08-01 | BIIB | Sale | 3,655 | 146.30 | 534,726 |
| 2012-07-17 | BIIB | Sale | 2,472 | 146.04 | 361,010 |
| 2012-07-16 | BIIB | Option Ex | 21,339 | .00 | 0 |
| 2012-07-02 | BIIB | Sale | 1,183 | 143.50 | 169,760 |
| 2012-06-01 | BIIB | Sale | 1,183 | 128.63 | 152,169 |
| 2012-02-10 | BIIB | Option Ex | 18,833 | .00 | 0 |
| 2011-07-20 | BIIB | Sale | 12,347 | 106.42 | 1,313,992 |
| 2011-07-15 | BIIB | Option Ex | 21,341 | .00 | 0 |
Table 4. Insider trading of Vir Biotechnology, Inc. (VIR) by Scangos George A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-24 | VIR | Sale | 10,056 | 9.45 | 95,059 |
| 2025-02-18 | VIR | Sale | 10,964 | 9.81 | 107,578 |
| 2024-02-26 | VIR | Sale | 17,722 | 11.65 | 206,514 |
| 2024-02-22 | VIR | Sale | 10,028 | 10.05 | 100,741 |
| 2024-02-16 | VIR | Sale | 10,878 | 10.24 | 111,390 |
| 2024-02-20 | VIR | Sale | 16,872 | 10.22 | 172,381 |
| 2023-02-24 | VIR | Sale | 15,119 | 23.15 | 349,959 |
| 2023-02-23 | VIR | Sale | 12,631 | 25.97 | 328,064 |
| 2023-02-21 | VIR | Sale | 17,856 | 28.41 | 507,253 |
| 2023-02-17 | VIR | Sale | 9,894 | 25.29 | 250,199 |
| 2022-02-17 | VIR | Sale | 10,024 | 31.93 | 320,076 |
| 2022-02-18 | VIR | Sale | 17,726 | 30.65 | 543,301 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Scangos George A
(Director of Vir Biotechnology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.